Sight Sciences Inc SGHT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:26 PM EDT
5.82quote price arrow up+0.21 (+3.74%)
Volume
38,888
52 week range
1.04 - 11.00
Loading...
  • Open5.61
  • Day High5.89
  • Day Low5.59
  • Prev Close5.61
  • 52 Week High11.00
  • 52 Week High Date05/05/23
  • 52 Week Low1.04
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap288.401M
  • Shares Out49.55M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta2.82
  • YTD % Change14.05

KEY STATS

  • Open5.61
  • Day High5.89
  • Day Low5.59
  • Prev Close5.61
  • 52 Week High11.00
  • 52 Week High Date05/05/23
  • 52 Week Low1.04
  • 52 Week Low Date10/27/23
  • Market Cap288.401M
  • Shares Out49.55M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta2.82
  • YTD % Change14.05

RATIOS/PROFITABILITY

  • EPS (TTM)-1.14
  • P/E (TTM)-5.09
  • Fwd P/E (NTM)-5.98
  • EBITDA (TTM)-56.662M
  • ROE (TTM)-39.64%
  • Revenue (TTM)81.055M
  • Gross Margin (TTM)85.34%
  • Net Margin (TTM)-68.53%
  • Debt To Equity (MRQ)28.22%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sight Sciences Inc

 

Profile

MORE
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult...
Staffan Encrantz
Independent Chairman of the Board
Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
Sam Park
Chief Operating Officer
Alison Bauerlein
Chief Financial Officer, Chief Accounting Officer, Treasurer
Address
4040 Campbell Ave,, Suite 100
Menlo Park, CA
94025
United States

Top Peers

SYMBOLLASTCHG%CHG
LUNG
Pulmonx Corp
9.63+0.25+2.67%
AKYA
Akoya Biosciences Inc
3.93-0.06-1.50%
SMLR
Semler Scientific Inc
26.92+0.40+1.51%
BFLY
Butterfly Network Inc
0.9869+0.0646+7.0042%
STIM
Neuronetics Inc
3.70+0.20+5.71%